Gastrointestinal Stromal Tumors
"Gastrointestinal Stromal Tumors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).
| Descriptor ID |
D046152
|
| MeSH Number(s) |
C04.557.450.565.370 C06.301.371.308 C06.405.249.308
|
| Concept/Terms |
Gastrointestinal Stromal Tumors- Gastrointestinal Stromal Tumors
- Stromal Tumor, Gastrointestinal
- Stromal Tumors, Gastrointestinal
- Tumor, Gastrointestinal Stromal
- Tumors, Gastrointestinal Stromal
- Gastrointestinal Stromal Neoplasms
- Neoplasm, Gastrointestinal Stromal
- Neoplasms, Gastrointestinal Stromal
- Stromal Neoplasm, Gastrointestinal
- Stromal Neoplasms, Gastrointestinal
- Gastrointestinal Stromal Tumor
- Gastrointestinal Stromal Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Gastrointestinal Stromal Tumors".
Below are MeSH descriptors whose meaning is more specific than "Gastrointestinal Stromal Tumors".
This graph shows the total number of publications written about "Gastrointestinal Stromal Tumors" by people in this website by year, and whether "Gastrointestinal Stromal Tumors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 4 | 1 | 5 |
| 2005 | 7 | 0 | 7 |
| 2006 | 12 | 1 | 13 |
| 2007 | 16 | 1 | 17 |
| 2008 | 9 | 4 | 13 |
| 2009 | 13 | 0 | 13 |
| 2010 | 13 | 1 | 14 |
| 2011 | 9 | 1 | 10 |
| 2012 | 4 | 2 | 6 |
| 2013 | 8 | 0 | 8 |
| 2014 | 13 | 0 | 13 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 6 | 0 | 6 |
| 2019 | 6 | 0 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 10 | 0 | 10 |
| 2022 | 4 | 1 | 5 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrointestinal Stromal Tumors" by people in Profiles.
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nat Med. 2024 Feb; 30(2):498-506.
-
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor. Clin Cancer Res. 2023 09 15; 29(18):3659-3667.
-
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study. Eur J Cancer. 2023 10; 192:113245.
-
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718.
-
A Rare PDGFRA Exon 15 Germline Mutation Identified in a Patient With Phenotypic Manifestations Concerning for GIST-Plus Syndrome: A Case Report and Review of Literature. Int J Surg Pathol. 2023 Sep; 31(6):1139-1145.
-
Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know. Surg Oncol Clin N Am. 2022 07; 31(3):341-360.
-
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma. ESMO Open. 2022 08; 7(4):100520.
-
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers. Clin Cancer Res. 2022 04 01; 28(7):1268-1276.
-
Is minimally invasive surgery for large gastric GIST actually safe? A comparative analysis of short- and long-term outcomes. Surg Endosc. 2022 09; 36(9):6975-6983.
-
Robotic excision of gastric and duodenal gastrointestinal stromal tumor. Updates Surg. 2022 Aug; 74(4):1483-1484.